Publications show all

Cardioxyl Pharmaceuticals has published 2 articles.

Patents show all

83Applications51Issued

Clinical Trials show all

2Phase 21N/A1Phase 11Phase 1/Phase 2

SEC Filings show all

D4

SEC Form D Funding Events

DateOfferedSoldType
2012-11-07$28,050,000$28,050,000Equity
2010-07-30$15,000,000$15,000,000Equity
2009-08-20$9,000,000$9,000,000Equity, Security to be Acquired
2006-11-15UnknownUnknownOther (Paper Filing)

Key Executives

  • Christopher A. Kroeger
    Executive Officer, Director
  • Reza Mazhari
    Executive Officer
  • John Barrett
    Director
  • Jeff Clark
    Director
  • Robert Garland
    Director
  • Charles Sanders
    Director
  • James Barrett
    Director
  • Doug Cowart
    Director
  • John Reardon
    Director
  • Vince Kalish
    Executive Officer
  • Gary Stiles
    Director
  • Anthony Johnson
    Director
  • Peter Thompson
    Director